Does denosumab not only prevent fractures, but also bone erosions in rheumatoid arthritis?
作者信息
Marsman Anneke F, Heslinga Sjoerd C, Lems Willem F
机构信息
Department of Rheumatology, Amsterdam University Medical Center, location VUmc.
出版信息
Rheumatol Adv Pract. 2022 Jul 5;6(2):rkac052. doi: 10.1093/rap/rkac052. eCollection 2022.
Abstract
摘要
相似文献
1
Does denosumab not only prevent fractures, but also bone erosions in rheumatoid arthritis?地诺单抗是否不仅能预防骨折，还能预防类风湿性关节炎中的骨侵蚀？
Rheumatol Adv Pract. 2022 Jul 5;6(2):rkac052. doi: 10.1093/rap/rkac052. eCollection 2022.
2
Denosumab, cortical bone and bone erosions in rheumatoid arthritis.地诺单抗、类风湿关节炎中的皮质骨与骨侵蚀
Ann Rheum Dis. 2016 Oct;75(10):e70. doi: 10.1136/annrheumdis-2016-210022. Epub 2016 Jun 23.
3
Repair of Bone Erosion in Rheumatoid Arthritis by Denosumab: A High-Resolution Peripheral Quantitative Computed Tomography Study.地舒单抗治疗类风湿关节炎骨侵蚀：高分辨率外周定量计算机断层扫描研究。
Arthritis Care Res (Hoboken). 2017 Aug;69(8):1156-1163. doi: 10.1002/acr.23133. Epub 2017 Jul 10.
4
Effect of antiresorptive and bone forming treatments in bone erosions in rheumatoid arthritis.抗吸收和骨形成治疗对类风湿关节炎骨侵蚀的影响。
Med Clin (Barc). 2020 May 8;154(9):358-365. doi: 10.1016/j.medcli.2019.12.005. Epub 2020 Feb 26.
5
The Effect of Teriparatide for the Treatment of Multiple Spontaneous Clinical Vertebral Fractures after Discontinuation of Denosumab in a Female Patient with Rheumatoid Arthritis: A Case Report.特立帕肽治疗类风湿关节炎女性患者停用地诺单抗后多发自发性临床椎体骨折的疗效：一例报告
Tohoku J Exp Med. 2021 May;254(1):57-61. doi: 10.1620/tjem.254.57.
6
Separately tackling the development of erosions with denosumab: ultimately closing a gap in the treatment of patients with rheumatoid arthritis or trying too hard too late?用地诺单抗分别应对糜烂的发展：最终是弥合类风湿关节炎患者治疗的差距，还是为时已晚、努力过头？
Ann Rheum Dis. 2016 Jun;75(6):947-9. doi: 10.1136/annrheumdis-2015-208863. Epub 2016 Feb 9.
7
Emerging treatments for postmenopausal osteoporosis - focus on denosumab.绝经后骨质疏松症的新兴治疗方法——聚焦地舒单抗。
Clin Interv Aging. 2009;4:241-50. doi: 10.2147/cia.s3333. Epub 2009 Jun 9.
8
The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study.抗 RANKL 抗体地舒单抗在类风湿关节炎患者临床骨折预防中的真实世界效果：ANSWER 队列研究。
Mod Rheumatol. 2022 Jul 1;32(4):834-838. doi: 10.1093/mr/roab043.
9
The sonographic identification of cortical bone interruptions in rheumatoid arthritis: a morphological approach.类风湿关节炎中皮质骨中断的超声识别：一种形态学方法。
Ther Adv Musculoskelet Dis. 2021 Apr 16;13:1759720X211004326. doi: 10.1177/1759720X211004326. eCollection 2021.
10
Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis : Denosumab improves bone mineral density in osteoporosis with rheumatoid arthritis.在类风湿关节炎相关性骨质疏松症中，无论是否进行双膦酸盐预处理，地诺单抗均可显著提高骨密度：地诺单抗可提高类风湿关节炎相关性骨质疏松症的骨密度。
Arch Osteoporos. 2017 Sep 21;12(1):80. doi: 10.1007/s11657-017-0371-y.
引用本文的文献
1
Chronic arthritides and bone structure: focus on rheumatoid arthritis-an update.慢性关节炎与骨结构：关注类风湿关节炎——更新
Aging Clin Exp Res. 2023 Jul;35(7):1405-1416. doi: 10.1007/s40520-023-02432-9. Epub 2023 May 24.
本文引用的文献
1
Therapeutic efficacy of denosumab for rheumatoid arthritis: a systematic review and meta-analysis.地诺单抗治疗类风湿关节炎的疗效：一项系统评价和荟萃分析。
Rheumatol Adv Pract. 2021 Dec 17;5(3):rkab099. doi: 10.1093/rap/rkab099. eCollection 2021.
2
Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction.确定类风湿关节炎亚组，以便用抗 RANKL 抗体地舒单抗进行干预，以减少关节破坏的进展。
RMD Open. 2020 Jul;6(2). doi: 10.1136/rmdopen-2020-001249.
3
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.绝经后妇女骨质疏松症的药物治疗：内分泌学会临床实践指南*。
J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622. doi: 10.1210/jc.2019-00221.
4
Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis.生物制剂初治类风湿关节炎患者换用地舒单抗或每日特立帕肽对影像学关节破坏进展的影响。
Osteoporos Int. 2018 Jul;29(7):1627-1636. doi: 10.1007/s00198-018-4492-y. Epub 2018 Mar 24.
5
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension.地舒单抗停药后发生的椎体骨折：一项 FREEDOM 随机安慰剂对照试验及其延伸的事后分析。
J Bone Miner Res. 2018 Feb;33(2):190-198. doi: 10.1002/jbmr.3337. Epub 2017 Nov 22.
6
Effect of oral clodronate on structural damage and bone turnover in rheumatoid arthritis.氯膦酸二钠对类风湿关节炎结构损伤和骨转换的影响。
Clin Exp Rheumatol. 2012 Jan-Feb;30(1):114-7. Epub 2012 Mar 7.
7
High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis.OSTRA 队列研究中椎体和非椎体骨折的高发率：一项对绝经后类风湿关节炎女性的 5 年随访研究。
Osteoporos Int. 2011 Sep;22(9):2413-9. doi: 10.1007/s00198-010-1517-6. Epub 2011 Jan 13.
8
Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial.地诺单抗与阿仑膦酸钠对低骨量绝经后妇女骨密度及骨转换生化标志物影响的比较：一项随机、双盲、3期试验
J Bone Miner Res. 2009 Jan;24(1):153-61. doi: 10.1359/jbmr.0809010.
9
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.地诺单抗对类风湿关节炎结构损伤、骨密度和骨转换的治疗效果：一项为期十二个月的多中心、随机、双盲、安慰剂对照的II期临床试验。
Arthritis Rheum. 2008 May;58(5):1299-309. doi: 10.1002/art.23417.
10
Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis.新型双膦酸盐唑来膦酸对早期类风湿关节炎结构改善作用的初步证据。
Arthritis Rheum. 2006 May;54(5):1410-4. doi: 10.1002/art.21824.
Zotero 插件